Public Accounts Committee publishes report on the Cancer Drugs Fund
5 February 2016 | By Victoria White
A Public Accounts Committee has released its recommendations for the reform of the Cancer Drugs Fund...
List view / Grid view
News
Honeywell completes acquisition of research chemicals business from Sigma-Aldrich
5 February 2016 | By Honeywell
The acquisition broadens Honeywell’s research chemicals portfolio and expands the company's global reach...
Aridhia’s Dr David Sibbald honoured with Outstanding Contribution Award
5 February 2016 | By Victoria White
Dr David Sibbald OBE, co-founder and Chairman of Aridhia, was awarded the ‘Outstanding Contribution Award’ at the Scottish Enterprise Life Sciences Awards...
Muzammil Mansuri is Sanofi’s new Executive Committee member
5 February 2016 | By Victoria White
Mr. Mansuri joins Sanofi from Gilead Sciences and will take the position of Executive Vice President, Strategy & Business Development...
Positive topline results from GAUSS-3 trial of Repatha
5 February 2016 | By Victoria White
The Phase 3 GAUSS-3 trial evaluating Amgen’s Repatha (evolocumab) in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints...
NovaBiotics wins Life Science Investment of the Year Award
5 February 2016 | By Victoria White
NovaBiotics was awarded the Life Science Investment of the Year Award at the Scottish Enterprise Life Sciences Annual Awards...
Ocean Optics Expands Flame Spectrometer Line with Versatile Miniature NIR Spectrometer
Flame-NIR puts the power of NIR analysis in a small-footprint instrument...
Phase 3 study of Blincyto in ALL meets primary endpoint
5 February 2016 | By Victoria White
Blincyto is a BiTE antibody construct that binds specifically to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells...
CPhI announces findings from its review of the US pharma manufacturing market
5 February 2016 | By Victoria White
Overall, the review demonstrates that US pharma industry and domestic manufacturers are showing increased confidence of renewed growth...
Continuous processing will require a change in mindset for controls and automation
4 February 2016 | By L.B. Bohle Maschinen + Verfahren GmbH
Continuous processing for secondary manufacturing in pharma is still one of the hottest topics currently discussed...
Orphan Drug Designation for acute spinal cord injury treatment
4 February 2016 | By Victoria White
AST-OPC1 has three potentially reparative functions that address the complex pathologies observed at the injury site of a spinal cord injury...
PDAC supports effectiveness of Brintellix in treating cognitive dysfunction in MDD
4 February 2016 | By Victoria White
The FDA Advisory Committee reviewed data from studies designed to assess the effect of Brintellix on cognitive dysfunction in adult patients with MDD...
Boehringer Ingelheim’s Spiriva Respimat available in the US
4 February 2016 | By Victoria White
Unlike other asthma daily maintenance treatments, Spiriva Respimat is from a new class of medications in asthma known as long-acting anticholinergics...
CHIRAL ART polysaccharide HPLC columns by YMC now with 3 µm!
To overcome the need of method developers for faster and high-resolution methods, YMC now offers all of its CHIRAL ART polysaccharide HPLC columns with a particle size of 3 µm.
FDA grants Fast Track Designation to TapImmune’s TPIV 200
3 February 2016 | By Victoria White
The FDA has granted the designation for maintenance therapy in subjects with platinum-sensitive advanced ovarian cancer...
